Patents | Published:

Equivalents in biotechnology patents

Nature Biotechnology volume 21, pages 329331 (2003) | Download Citation

Subjects

Post-Festo, can the doctrine of equivalents still be effective in asserting infringement of a claimed invention? The answer is yes, but with great difficulty.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 535 US ----; 62 USPQ2d 1705 (No. 00-1543) (2002).

  2. 2.

    Graver Tank & Mfg. Co. v. Linde Air Products Co., 339 US 605; 85 USPQ 328 (1950).

  3. 3.

    Warner-Jenkinson Co. v. Hilton Davis Chemical Co., 520 US 17; 41 USPQ2d 1865 (1997).

  4. 4.

    Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 56 USPQ2d 1865 (Fed. Cir. 2000).

  5. 5.

    University of California v. Eli Lilly and Co., 43 USPQ2d 1398 (Fed. Cir. 1997).

  6. 6.

    Mycogen Plant Science Inc. v. Monsanto Co., 59 USPQ2d 1852 (Fed. Cir. 2001), rehearing of Mycogen Plant Science Inc. v. Monsanto Co., 58 USPQ2d 1891 (Fed. Cir. 2001).

  7. 7.

    Genentech Inc. v. The Wellcome Foundation Ltd., 31 USPQ2d 1161 (Fed. Cir. 1994).

  8. 8.

    Abbott Laboratories v. Dey L.P., 62 USPQ2d 1545 (Fed. Cir. 2002).

  9. 9.

    Johnson & Johnston Associates Inc. v. R.E. Service Co., 62 USPQ2d 1225 (Fed. Cir. 2002).

Download references

Author information

Affiliations

  1. Henry E. Auer is president of Proteus Patent Practice LLC, P.O. Box 1867, New Haven, CT 06508 proteuspatent@snet.net.

    • Henry E. Auer

Authors

  1. Search for Henry E. Auer in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt0303-329